{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:49:40Z","timestamp":1782730180330,"version":"3.54.5"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: Essential hypertension is linked to increased maternal and perinatal risks. The aim of this study was to assess women with essential hypertension and poor obstetric history before conception to identify co-morbidities and placenta-related risk factors and to examine how preconception evaluation affects future pregnancy outcomes.  METHODS: This retrospective cohort study involved women with poor obstetric history, with (n=25) or without (n=243) essential hypertension. Women were evaluated for co-morbidities and metabolic, immunological, inflammatory, and vascular\/thrombotic risk factors. Subsequent pregnancies were then assessed for gestational outcomes.  RESULTS: Higher levels of co-morbidity were found in the essential hypertension (+) group compared to high-risk controls (68 vs. 39.9%, p=0.013). Essential hypertension (+) women had significantly higher rates of chronic inflammatory diseases (28 vs. 5.8%, p=0.001) and carbohydrate metabolism disorders (44 vs. 10.3%, p&lt;0.001) than in controls. Except for \u201cAPGAR&lt;7\u201d (p=0.016), we were unable to show any statistically significant differences between the study and control groups in terms of placenta-related obstetric complications and gestational outcomes in their forthcoming pregnancies due to necessary precautions and timely management of risk factors.  CONCLUSION: Chronic inflammatory diseases and carbohydrate metabolism disorders, which are risk factors for both endothelial injury and placenta-related obstetric complications, are more frequently observed in pregnancies with essential hypertension. Preconception counseling is critical in reducing gestational complications.<\/jats:p>","DOI":"10.1590\/1806-9282.20251913","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:42:16Z","timestamp":1782729736000},"source":"Crossref","is-referenced-by-count":0,"title":["Pre-pregnancy evaluation of essential hypertensive women with poor obstetric history"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-4401","authenticated-orcid":false,"given":"Murat","family":"Cagan","sequence":"first","affiliation":[{"name":"Hacettepe University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7413-4939","authenticated-orcid":false,"given":"Hanife Guler","family":"Donmez","sequence":"additional","affiliation":[{"name":"Hacettepe University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-2517","authenticated-orcid":false,"given":"Erdem","family":"Fadiloglu","sequence":"additional","affiliation":[{"name":"Hacettepe University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-3037","authenticated-orcid":false,"given":"Gonca","family":"Ozten","sequence":"additional","affiliation":[{"name":"Hacettepe University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-787X","authenticated-orcid":false,"given":"Mehmet Sinan","family":"Beksac","sequence":"additional","affiliation":[{"name":"Hacettepe University,  T\u00fcrkiye; \u0130stinye University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG practice bulletin No. 203: chronic hypertension in pregnancy.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"2S","key":"ref2","doi-asserted-by":"crossref","first-page":"S1196","DOI":"10.1016\/j.ajog.2020.07.026","article-title":"Toward personalized management of chronic hypertension in pregnancy.","volume":"226","author":"Magee LA","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension.","volume":"956","author":"Konukoglu D","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide.","volume":"10","author":"Sun HJ","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/ars.2013.5258","article-title":"The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.","volume":"20","author":"Crowley SD","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: updates in pathogenesis, definitions, and guidelines.","volume":"11","author":"Phipps E","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1080\/14767058.2020.1760834","article-title":"Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation.","volume":"35","author":"Beksac MS","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7864816","DOI":"10.1155\/2020\/7864816","article-title":"Future directions: analyzing health disparities related to maternal hypertensive disorders.","volume":"2020","author":"Harris M","year":"2020","journal-title":"J Pregnancy"},{"issue":"1","key":"ref10","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000002897","article-title":"ACOG Committee Opinion No. 755: well-woman visit.","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.fertnstert.2018.12.003","article-title":"Prepregnancy counseling: committee opinion No. 762.","volume":"111","year":"2019","journal-title":"Fertil Steril"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14779072.3.1.43","article-title":"Use of nifedipine in the treatment of hypertension.","volume":"3","author":"Pontremoli R","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2010.11.038","article-title":"Nifedipine in the management of preterm labor: a systematic review and metaanalysis.","volume":"204","author":"Conde-Agudelo A","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"ref15","first-page":"936","article-title":"Essential hypertension and pregnancy.","volume":"118","author":"Bear RA","year":"1978","journal-title":"Can Med Assoc J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preghy.2019.08.166","article-title":"Management of non-severe pregnancy hypertension - a summary of the CHIPS Trial (Control of Hypertension in Pregnancy Study) research publications.","volume":"18","author":"Magee LA","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3864941","DOI":"10.1155\/2020\/3864941","article-title":"The role of inflammation in the pathogenesis of preeclampsia.","volume":"2020","author":"Michalczyk M","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/febs.15745","article-title":"Revisiting preeclampsia: a metabolic disorder of the placenta.","volume":"289","author":"Hu M","year":"2022","journal-title":"FEBS J"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review.","volume":"170","author":"Abalos E","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"42","key":"ref20","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.","volume":"101","author":"Chiang N","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"ref21","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1182\/bloodadvances.2023011895","article-title":"LMWH prevents thromboinflammation in the placenta via HBEGF-AKT signaling.","volume":"8","author":"Singh KK","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bmb\/ldy035","article-title":"The management of hypertension in women planning for pregnancy.","volume":"128","author":"Lu Y","year":"2018","journal-title":"Br Med Bull"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/1471-0528.13568","article-title":"Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?","volume":"123","author":"Magee LA","year":"2016","journal-title":"BJOG"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1471-0528.13680","article-title":"The benefits\/risks of treatment of non-severe hypertension in pregnancy and choice of drug remain unanswered.","volume":"123","author":"Sibai BM","year":"2016","journal-title":"BJOG"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1258\/om.2011.110061","article-title":"Hypertension in pregnancy: a review of therapeutic options.","volume":"5","author":"Kernaghan D","year":"2012","journal-title":"Obstet Med"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000402219&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:42:19Z","timestamp":1782729739000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000402219&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000402219"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20251913","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20251913"}}